ATOMIC AI Trademark

Trademark Overview


On Thursday, August 19, 2021, a trademark application was filed for ATOMIC AI with the United States Patent and Trademark Office. The USPTO has given the ATOMIC AI trademark a serial number of 90890805. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Monday, January 29, 2024. This trademark is owned by ATOMATAI, INC.. The ATOMIC AI trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for the modification of RNA expression and alteration of RNA translation for the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes

research and development of pharmaceuticals, namely, therapies for the modification of RNA expression and alteration of RNA translation, used in the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; research and development in the fields of biotechnology, DNA, RNA, molecules and proteins; automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; drug design and development featuring machine-learning algorithms and lab automation tools; developing customized software in the field of drug desi...
atomic ai

General Information


Serial Number90890805
Word MarkATOMIC AI
Filing DateThursday, August 19, 2021
Status654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED
Status DateMonday, January 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicespharmaceutical preparations for the modification of RNA expression and alteration of RNA translation for the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes
Disclaimer with Predetermined Text"AI"
Goods and Servicesresearch and development of pharmaceuticals, namely, therapies for the modification of RNA expression and alteration of RNA translation, used in the treatment of cancers and autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, hypertension, pain, stroke, obesity and diabetes; research and development in the fields of biotechnology, DNA, RNA, molecules and proteins; automated design and development of biomolecules for medical and scientific use, for use in the manufacture of biosensors, agriculture, synthetic biological research, laboratories and environmental safety and testing; drug design and development featuring machine-learning algorithms and lab automation tools; developing customized software in the field of drug design and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 6, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameATOMATAI, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events


Event DateEvent Description
Monday, January 29, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, July 31, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Tuesday, January 31, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 31, 2023LETTER OF SUSPENSION E-MAILED
Tuesday, January 31, 2023SUSPENSION LETTER WRITTEN
Saturday, January 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 9, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 9, 2023NON-FINAL ACTION E-MAILED
Monday, January 9, 2023NON-FINAL ACTION WRITTEN
Thursday, November 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 24, 2022NON-FINAL ACTION WRITTEN
Monday, May 23, 2022ASSIGNED TO EXAMINER
Wednesday, October 6, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 23, 2021NEW APPLICATION ENTERED